Pyrazinamide丨CAS 98-96-4

Pyrazinamide丨CAS 98-96-4
Product Introduction:
Catalog No.: SS130917
CAS No.: 98-96-4
Grade/Purity: BP2022
Product Name: Pyrazinamide
Molecular Formula: C5H5N3O
Molecular Weight: 123.11
Send Inquiry
Technical Parameters
Description

Hangzhou Leap Chem Co., Ltd. is one of the most professional manufacturers and suppliers of pyrazinamide丨cas 98-96-4 in China. Welcome to wholesale bulk high quality chemical products at competitive price from our factory. If you have any enquiry about custom service, please feel free to email us.

 

Specifications

 

Grade BP2022
Appearance White to off-white crystal powder
Assay (on anhydrous basis) 98% to 101%
Solubility Conforms
Identification ABC Conforms
Melting Point (M.P.) 188-191℃
Solution Clear and colorless
Acidity Conforms
Related Substance (HPLC) - Impurity B 0.1% max
Related Substance (HPLC) - Unspecified impurities 0.05% max
Related Substance (HPLC) - Total impurities 0.2% max
Heavy metals 10 ppm max
Water (KF) 0.5% max
Sulphated ash 0.1% max

 

 

 

Applications

 

Pyrazinamide is an important synthetic antimicrobial agent widely used in the treatment of tuberculosis (TB). It is classified as a first-line antitubercular drug and is typically included in combination therapies with isoniazid, rifampicin, and ethambutol to shorten the duration of TB treatment. Its unique activity against Mycobacterium tuberculosis in acidic environments, such as within macrophages and necrotic lesions, makes it a critical component for eradicating semi-dormant bacterial populations that are otherwise resistant to many other agents. Beyond tuberculosis, pyrazinamide has been studied for its potential use against other intracellular pathogens and in experimental chemotherapeutic regimens. Additionally, it serves as a reference compound in pharmacological research and drug metabolism studies, supporting the development of novel antimycobacterial therapies.

 

Benefits

 

The major benefits of pyrazinamide stem from its ability to target M. tuberculosis in latent or slowly replicating forms, thereby reducing the overall duration of therapy from 9–12 months to 6 months when included in multidrug regimens. This not only improves patient compliance but also lowers the risk of drug resistance development. Its oral bioavailability, good tissue penetration, and synergistic action with other TB drugs contribute to its effectiveness in both pulmonary and extrapulmonary tuberculosis. By helping to sterilize lesions, pyrazinamide prevents relapse and enhances cure rates. Its inclusion in standard TB therapy is considered a cornerstone in global tuberculosis control strategies, making it indispensable in public health efforts.

 

Conclusion

 

In conclusion, pyrazinamide is a vital antitubercular medication with a unique mechanism of action that complements other first-line drugs. Its ability to act in acidic environments, shorten treatment duration, and reduce relapse risk underscores its importance in modern TB therapy. As research into tuberculosis and resistant strains continues, pyrazinamide remains a key therapeutic agent, playing a central role in effective treatment protocols and global efforts to control and eventually eradicate tuberculosis.

 

 

Send Inquiry
Beyond Your Expectation
From Science to Life with LEAPChem
contact us